Clinical trial
Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu)…
NCT00115427 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00115427 |
|---|---|
| Title | Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease |
| Official title | Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's Disease |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Idiopathic Parkinson's Disease |
| Intervention type | Drug |
| Interventions | Liatermin (r-metHuGDNF) |
| Start date | Mar 1, 2003 |
| First posted | Jun 23, 2005 |
| Last update posted | Jan 11, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: